[TRAC] KALO: clinical study

site secured by GeoTrust | verified member of PayPal

> KALO - Clinical Study

Kalo Clinical Study

Conducted at the I. M. Sechenov Clinic, Moscow
October 31, 2000

Summary

This is a summary of results of the experimental treatment with Kalo Hair Growth Inhibitor.

Methodology

There were 17 women under observation in the study, aged from 33-58 years old. All of the women in the study were suffering from abundant hair growth in various areas of the body. The women had been suffering from unwanted hair for between 13-35 years. All of the women studied had previously tried various methods of hair removal including (shaving, tweezing, electrolysis and various depilatory creams.) The frequency of the previous removal methods varied from every day to once a year.

Hair epilation in the course of the test was carried out in the I. M. Sechenov Clinic of Skin Diseases of Moscow Medical Academy (MMA) by means of application of "GiGi" Brand wax provided by Nisim International. Following the waxing Kalo Hair Inhibitor was applied in 3 applications with 15 minute intervals on the first day. Kalo was applied 3 times the following day with the same intervals.

Results

Four of the women studied removed hair in the underarm region. Each patient had a total of 6 hair removal and Kalo sessions. All of the women showed a significant decrease in the frequency of epilation from one time in 2 weeks to 1 time in 5-6 weeks. This confirmed the slowing down of hair growth in the underarm area. All of the patients showed a 65-75% decrease of hair in the 1 sq. cm. area examined. All of the women also noticed a decrease in the pigmentation of the hair that grew back was noticeably finer.
Subjective evaluation of both the Doctor and the Patients - 90 out of 100.

Five of the women studied removed hair on the leg. Each patient had a total of 6-7 hair removal and Kalo sessions. All of the women showed a significant decrease in the frequency of epilation from one time in 2 weeks to 1 time in 5-6 weeks. This confirmed the slowing down of hair growth in the leg area. All of the patients showed a 50-65% decrease of hair in the 1 sq. cm. area examined. All of the women also noticed a decrease in the pigmentation of the hair that grew back was finer.
Subjective evaluation of both the Doctor and the Patients - 80 out of 100.

Three of the women studied removed hair from the bikini area. Each patient had a total of 6-7 hair removal and Kalo sessions. All of the women showed a moderate decrease in the frequency of epilation from one time in 3 weeks to 1 time in 4 weeks. This confirmed the slowing down of hair growth in the bikini area. All of the patients showed a slight decrease of hair in the 1 sq. cm. area examined of approximately 20-40%. All of the women also noticed a decrease in the pigmentation of the hair that grew back was finer.
Subjective evaluation of both the Doctor and the Patients - 60 out of 100.

Five of the women studied removed hair on the face and neck. Each patient had a total of 6 hair removal and Kalo sessions. A slight slow down of growth was noticed in 2 patients with the frequency of epilation decreasing by one week in the other 3 patients there was not any significant change noticed. In three of the women we noticed a decrease in pigmentation. In two of the women no significant change was noticed. There was a decrease in the hair in the 1 sq. cm. area of approximately 15-30%.
Subjective evaluation of both the Doctor and the Patients - 40-50 out of 100.

Discussion

All of the test patients were pleased with the ease of application and the soothing effect of Kalo. During the entire duration of the test no side effects were observed by any of the patients.

The tests carried out by us demonstrated a relatively high efficacy of the Kalo Hair Inhibitor when applied to the underarm and leg areas and only a less noticeable reduction of hair in the bikini and facial areas.

E.V. Mareeva
Senior Assistant of the Chair
Of the Skin and Venereal Diseases of the I. M. Sechenov MMA Clinic

	Sitemap \| Affiliates \| Retail Partners \| TRAC FAQ \| Privacy & Policy \| Contact
	The above statements are for informational purposes only and have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, prevent, or cure any diseases or medical conditions.
	Copyright © 2005 TRAC Distribution Corp. No reproduction in whole or in part without written permission. All Rights Reserved. All trademarks and product images exhibited on this site, unless otherwise indicated, are the property of TRAC Distribution Corp.